Sullivan, Amy B.
Hersh, Carrie M.
Rensel, Mary
Benzil, Deborah
Article History
First Online: 26 January 2023
Declarations
:
: Dr. Deborah Benzil has no relevant disclosures.
: Dr. Amy Sullivan has received speaking, consulting and advisory board fees from Biogen, Novartis and Bristol Myers Squibb.Dr. Carrie Hersh has received speaking, consulting, and advisory board fees from Genentech, Genzyme, Biogen, Novartis, EMD-Serono, Bristol Myers Squibb, and TG Therapeutics. She has received research support paid directly to her institution by Biogen, Novartis, Genentech, Patient-Centered Outcomes Research Institute (PCORI) and NIH—NINDS 1U01NS111678-01A1 sub-award.
Free to read: This content has been made available to all.